𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C

✍ Scribed by Karin Lindahl; Lars Stahle; Annette Bruchfeld; Robert Schvarcz

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
97 KB
Volume
41
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of peginterferon alp
Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C
✍ Richard Njouom; Michèle Tagni Sartre; Isabelle Timba; Eric Nerrienet; Patrice Tc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract Data were examined from a day‐to‐day clinical practice in Yaounde, Cameroon to evaluate the efficacy and safety of peginterferon alfa‐2a and ribavirin in treatment‐naive Cameroonian patients with chronic hepatitis C. Ninety adults with chronic hepatitis C (mean age, 53 ± 8 years; 79% ma

Multicenter randomized study comparing i
Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis c
✍ Moisés Diago; Dolores Suárez; Luis García-Villarreal; Angeles Castro; Agustín Do 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

## Abstract One hundred fifty‐five chronic hepatitis C patients were assigned at random to receive natural lymphoblastoid interferon (IFN)α‐n1, s.c., for 13 months in one of three treatment regimens: initial daily induction with 10 million units (MU) followed (group 1, n = 50) or not (group 2, n = 

Limitation of combination therapy of int
Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a

Improved outcomes in patients with hepat
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin
✍ Michael W. Fried; Donald M. Jensen; Maribel Rodriguez-Torres; Lisa M. Nyberg; Ad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 1 views

Treatment response remains suboptimal for many patients with chronic hepatitis C, particularly those with genotype 1 and high levels of viremia. The efficacy of high-dose regimens of peginterferon alfa-2a and ribavirin was compared with conventional dose regimens in patients with features predicting

Treatment of insulin resistance with met
Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
✍ Manuel Romero-Gómez; Moisés Diago; Raúl J. Andrade; José L. Calleja; Javier Salm 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 309 KB

Insulin resistance affects sustained virological response (SVR) in chronic hepatitis C. To know whether adding metformin to standard antiviral treatment improves SVR, we conducted a prospective, multicentered, randomized, double-blinded, placebo-controlled trial in 19 Spanish hospitals, including 12